Why Some Brain Tumors Respond to Immunotherapy
Friday, February 15, 2019 - 15:10
in Health & Medicine
Columbia researchers have learned why some glioblastomas—the most common type of brain cancer—respond to immunotherapy. The findings could help identify patients who are most likely to benefit from treatment with immunotherapy drugs and lead to the development of more broadly effective treatments. The study, led by Raul Rabadan, PhD, professor of systems biology and biomedical informatics […]